By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Turn Therapeutics Inc.

Turn Therapeutics Inc. (TTRX)

NASDAQ Currency in USD
$58.00
+$1.14
+2.00%
Last Update: 18 Jul 2026, 11:32
$797.15m
Market Cap
P/E Ratio (TTM)
Forward Dividend Yield
$42.41-$79.05
52 Week Range

TTRX Stock Price Chart

Explore Turn Therapeutics Inc. interactive price chart. Choose custom timeframes to analyze TTRX price movements and trends.

TTRX Company Profile

Discover essential business fundamentals and corporate details for Turn Therapeutics Inc. (TTRX) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

8 Oct 2025

Employees

2.00

CEO

Bradley E. Burnam

Description

Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.

TTRX Financial Timeline

Browse a chronological timeline of Turn Therapeutics Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 2 Sept 2026

EPS estimate is -$0.02.

Upcoming earnings on 2 Sept 2026

EPS estimate is -$0.02.

Earnings released on 11 May 2026

EPS came in at -$0.03 falling short of the estimated -$0.02 by -50.00%.

Earnings released on 31 Mar 2026

EPS came in at -$0.09 falling short of the estimated -$0.05 by -76.47%.

Earnings released on 13 Nov 2025

EPS came in at -$0.07 .

TTRX Stock Performance

Access detailed TTRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run